Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Ernberg

Showing results (51-60 of 137) with videos related to

Pageof 14
Sort By:
Nature|March 17, 1977
Relationship between amount of Epstein-Barr virus-determined nuclear antigen per cell and number of EBV-DNA copies per cellI Ernberg, M Andersson-Anvret, G Klein, et al.
The Journal of General Virology|January 1, 1995
Coupled transcription of Epstein-Barr virus latent membrane protein (LMP)-1 and LMP-2B genes in nasopharyngeal carcinomasF Chen, L F Hu, I Ernberg, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Differential c-myc protein expression in Burkitt's lymphomas and EBV-transformed lymphoblastoid linesA D Wennborg, E Altiok, J P Moore, et al.
Journal of Medical Virology|April 1, 1997
Direct identification by PCR of EBV types and variants in clinical samplesK I Falk, J Z Zou, E Lucht, et al.
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1985
Acyclovir treatment in primary Epstein-Barr virus infection. A double-blind placebo-controlled studyJ Andersson, B Sköldenberg, I Ernberg, et al.
Journal of Medical Virology|August 1, 1995
Synthetic peptides deduced from the amino acid sequence of Epstein-Barr virus nuclear antigen 6 (EBNA 6): antigenic properties, production of monoreactive reagents, and analysis of antibody responses in manK Falk, A Linde, D Johnson, et al.
Cellular Immunology|January 1, 1978
Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. II. Epstein-Barr virus studiesL Einhorn, M Steinitz, E Yefenof, et al.
Virology|May 1, 1994
Sequence-specific methylation inhibits the activity of the Epstein-Barr virus LMP 1 and BCR2 enhancer-promoter regionsJ Minarovits, L F Hu, S Minarovits-Kormuta, et al.
Cancer Research|October 18, 2000
Differences in the immunogenicity of latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus genomes derived from LMP1-positive and -negative nasopharyngeal carcinomaL Hu, B Troyanovsky, X Zhang, et al.
International Journal of Cancer|March 15, 1985
Effect of cyclosporin-A (CsA) on the ability of T lymphocyte subsets to inhibit the proliferation of autologous EBV-transformed B cellsM T Bejarano, M G Masucci, I Ernberg, et al.
Pageof 14

Showing results (51-60 of 137) with videos related to

Sort By:
Pageof 14
Nature|March 17, 1977
Relationship between amount of Epstein-Barr virus-determined nuclear antigen per cell and number of EBV-DNA copies per cellI Ernberg, M Andersson-Anvret, G Klein, et al.
The Journal of General Virology|January 1, 1995
Coupled transcription of Epstein-Barr virus latent membrane protein (LMP)-1 and LMP-2B genes in nasopharyngeal carcinomasF Chen, L F Hu, I Ernberg, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Differential c-myc protein expression in Burkitt's lymphomas and EBV-transformed lymphoblastoid linesA D Wennborg, E Altiok, J P Moore, et al.
Journal of Medical Virology|April 1, 1997
Direct identification by PCR of EBV types and variants in clinical samplesK I Falk, J Z Zou, E Lucht, et al.
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1985
Acyclovir treatment in primary Epstein-Barr virus infection. A double-blind placebo-controlled studyJ Andersson, B Sköldenberg, I Ernberg, et al.
Journal of Medical Virology|August 1, 1995
Synthetic peptides deduced from the amino acid sequence of Epstein-Barr virus nuclear antigen 6 (EBNA 6): antigenic properties, production of monoreactive reagents, and analysis of antibody responses in manK Falk, A Linde, D Johnson, et al.
Cellular Immunology|January 1, 1978
Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. II. Epstein-Barr virus studiesL Einhorn, M Steinitz, E Yefenof, et al.
Virology|May 1, 1994
Sequence-specific methylation inhibits the activity of the Epstein-Barr virus LMP 1 and BCR2 enhancer-promoter regionsJ Minarovits, L F Hu, S Minarovits-Kormuta, et al.
Cancer Research|October 18, 2000
Differences in the immunogenicity of latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus genomes derived from LMP1-positive and -negative nasopharyngeal carcinomaL Hu, B Troyanovsky, X Zhang, et al.
International Journal of Cancer|March 15, 1985
Effect of cyclosporin-A (CsA) on the ability of T lymphocyte subsets to inhibit the proliferation of autologous EBV-transformed B cellsM T Bejarano, M G Masucci, I Ernberg, et al.
Pageof 14